Dr. Sonali Kochhar (MD)

Dr. Kochhar is a Clinical Research & Drug Development Specialist, who has extensive global experience in Vaccines and Drugs development for Infectious Diseases. She has been responsible for providing leadership for Clinical Development Strategy, Design, Implementation and Medical Oversight for international multi-centric, multi-country trials for PATh and other PPP. She has provided Clinical and Regulatory support for Phase I - IV international trials for Vaccines and Drugs conducted in adult and paediatric populations in the USA, Europe, India, Africa and Asia. She has also been responsible for scientific advocacy and partnership development with International and National Government Partners, Public Health Authorities, Regulatory Bodies, Scientific Authorities, International Pharmaceutical Companies, Local Communities and the Media. She works with Government partners for National Policy and Program Development. Dr Kochhar received her MD in Pharmacology from Delhi University, India, has completed the Advanced Vaccinology Course (ADVAC) at the University of Geneva/Fondation Mérieux in Annecy, France  and in Seoul, Korea (ADVAC Asia-Pacific). She has a degree in Epidemiology from the London School of Hygiene and Tropical Medicine. and served as Guest Faculty for several international Vaccinology and Clinical Research Professional Programs. Dr. Kochhar contributed to a number of vaccine safety standards for Malaria, Tuberculosis and AIDS Vaccine trials, the Global Health Clinical Consortium Leadership Group. 
In 2011, Dr. Kochhar was  a Yale World Fellow for 2011, has been awarded the Vaccinology Fellowship Award for significant achievements in Vaccinology from Fondation Mérieux and University of Geneva; Global Leadership Awards from Eli Lilly & Company, Indianapolis, U.S.A; the Bharat Jyoti (Light of India) Award, and the Serviers Young Investigator Award by Institute de Recherches Internationales, Servier, France, for Clinical Research.
​
​Dr. Kochhar is a founding member of the ViVI Scientific Think Tank since 2008 providing clinical trial and safety expertise.